Drugs / LUXSOL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02197182 | Jun 2014 → Mar 2015 | bacterial vaginosis | CDA Research Group, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUXSOL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02197182 ↗ |
| Route | Other | “LUXSOL is administered intravaginally for 10 days” NCT02197182 ↗ |